Literature DB >> 33743790

Assessing rare diseases prevalence using literature quantification.

Jason Shourick1, Maxime Wack2, Anne-Sophie Jannot2,3.   

Abstract

INTRODUCTION: Estimating the prevalence of diseases is crucial for the organization of healthcare. The amount of literature on a rare pathology could help differentiate between rare and very rare diseases. The objective of this work was to evaluate to what extent the number of publications can be used to predict the prevalence of a given pathology.
METHODS: We queried Orphanet for the global prevalence class for all conditions for which it was available. For these pathologies, we cross-referenced the Orphanet, MeSH, and OMIM vocabularies to assess the number of publication available on Pubmed using three different query strategies (one proposed in the literature, and two built specifically for this study). We first studied the association of the number of publications obtained by each of these query strategies with the prevalence class, then their predictive ability.
RESULTS: Class prevalence was available for 3128 conditions, 2970 had a prevalence class < 1/1,000,000, 41 of 1-9/1,000,000, 84 of 1-9/100,000, and 33 of 1-9/10,000. We show a significant association and excellent predictive performance of the number of publication, with an AUC over 94% for the best query strategy.
CONCLUSION: Our study highlights the link and the excellent predictive performance of the number of publications on the prevalence of rare diseases provided by Orphanet.

Entities:  

Keywords:  Bibliometrics; Prevalence; Rare diseases

Mesh:

Year:  2021        PMID: 33743790      PMCID: PMC7980535          DOI: 10.1186/s13023-020-01639-7

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  4 in total

Review 1.  Incidence and prevalence of 121 rare diseases in China: Current status and challenges: 2022 revision.

Authors:  Yanqin Lu; Qingxia Gao; Xiuzhi Ren; Junfeng Li; Dan Yang; Zijian Zhang; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2022-08

2.  Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study.

Authors:  Francesca Gorini; Michele Santoro; Anna Pierini; Lorena Mezzasalma; Silvia Baldacci; Elena Bargagli; Alessandra Boncristiano; Maurizia Rossana Brunetto; Paolo Cameli; Francesco Cappelli; Giancarlo Castaman; Barbara Coco; Maria Alice Donati; Renzo Guerrini; Silvia Linari; Vittoria Murro; Iacopo Olivotto; Paola Parronchi; Francesca Pochiero; Oliviero Rossi; Barbara Scappini; Andrea Sodi; Alessandro Maria Vannucchi; Alessio Coi
Journal:  Front Pharmacol       Date:  2022-05-16       Impact factor: 5.988

3.  Rare disorders have many faces: in silico characterization of rare disorder spectrum.

Authors:  Simona D Frederiksen; Vladimir Avramović; Tatiana Maroilley; Anna Lehman; Laura Arbour; Maja Tarailo-Graovac
Journal:  Orphanet J Rare Dis       Date:  2022-02-22       Impact factor: 4.123

4.  Rare disease-based scientific annotation knowledge graph.

Authors:  Qian Zhu; Chunxu Qu; Ruizheng Liu; Gunjan Vatas; Andrew Clough; Ðắc-Trung Nguyễn; Eric Sid; Ewy Mathé; Yanji Xu
Journal:  Front Artif Intell       Date:  2022-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.